Head to head for first-timers
Breeze Meds vs CareBareRX
Breeze Meds and CareBareRX both offer GLP-1 telehealth, but they make different trade-offs on how gentle the start is, honest pricing, real support and access. Here they are side by side on the Mama-Match Score — our first-timer rubric.
Breeze Meds
Higher scoreRank #9 for first-timers · Grade B−
Mama-Match
Best for: Moms who want named clinical oversight with no recurring-billing strings attached, and are comfortable confirming the exact price during intake.
Visit Breeze MedsCareBareRX
Rank #43 for first-timers · Grade C
Mama-Match
Best for: Moms who want both molecules and a brand option on one platform, don't mind a short intake to see real numbers, and will read all four plan-length tiers rather than assuming longer means cheaper.
Visit CareBareRXThe verdict for a first step
Breeze Meds edges out CareBareRX on the Mama-Match Score, 82 to 69 (B− vs C). Moms who want named clinical oversight with no recurring-billing strings attached, and are comfortable confirming the exact price during intake.
CareBareRX is still a genuine option — $199–249/mo semaglutide, $299–356/mo tirzepatide depending on plan — but you only see those numbers after the intake, and the 3-month plan costs more per month than monthly. Weigh the six first-timer factors below against your own priorities.
Side by side on all six factors
Both providers judged on the same first-timer rubric — the higher side on each factor is marked. See the methodology.
Price, access and features
| Detail | Breeze Meds | CareBareRX |
|---|---|---|
| Mama-Match Score | 82/100 · B− | 69/100 · C |
| Overall rank | #9 | #43 |
| Semaglutide | $199/mo (injectable, starting) | $199/mo month-to-month ($185/mo on the 12-month plan) |
| Tirzepatide | Priced after intake (from a $199 weight-loss floor) | $299/mo month-to-month ($293/mo on the 12-month plan) |
| Coverage | All 50 states | Advertised nationwide (not confirmed on site) |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Yes | Yes |
Mama-Match
Breeze Meds
Rank #9 · Grade B−
What we like
- Named clinicians (Lion MD) and named 503A pharmacies — real, verifiable oversight
- All 50 states, with an easy at-home questionnaire and no required video visit
- No subscription or membership strings; FSA/HSA eligible
The caveats
- Only a 'from $199' floor is published; exact per-medication and oral pricing appears after intake
- Compounded only, not FDA-approved brand-name pens
- Thin independent review footprint — a young brand
Mama-Match
CareBareRX
Rank #43 · Grade C
What we like
- Confirmed, tiered pricing on both molecules, compounded semaglutide and tirzepatide, including oral/tablet options
- Named pharmacies and physicians: Belmar, Strive, Epiq Scripts, Casa Pharma Rx; Lion MD
- Simple asynchronous intake with a provider review within 24 hours
The caveats
- No price appears anywhere on the public site — you have to start the intake to see any number
- The 3-month plan costs MORE per month than month-to-month or the 6-month plan, on both molecules
- State coverage and refund terms cited by third parties aren't confirmed on CareBareRX's own pages
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Mama-Match Score. Prices, states and verification reflect what each provider disclosed publicly at our last review; the Mama-Match Score is our editorial judgment under the methodology. Prices change — confirm them on each provider’s site. Not medical advice; see our disclosure.
More head-to-heads
Keep comparing Breeze Meds and CareBareRX with the other providers we review for women.
Or browse the full comparison hub.